Results 1 - 20 of 931 in J and J Snack Foods
-
Licensing Strategies - Examining Today's Pharmaceutical Licensing...
Licensing Strategies - Examining Today's Pharmaceutical Licensing Trends - New Research Report on Companies and Markets 2008-07-04 19:59:18 - www.companiesandmarkets.com adds new report - Licensing Strategies - ...
Comment?
-
PR-Sprints Two for Two: Dollansky Completes Season Sweep at Huset's Speedway
Author Topic: PR-Sprints Two for Two: Dollansky Completes Season Sweep at Huset's Speedway Two for Two: Dollansky Completes Season Sweep at Huset's Speedway with Win Thursday Night Brandon, SD- July 3, 2008-The ...
Comment?
-
Software Firm Focuses On Not-So-Blind Dates
Think of IdeaPoint as an online matchmaker bringing biotech inventors and biopharma companies together.
Comment?
-
Lessons From Johnson + Johnson
Knowledge @ Wharton has an enlightening interview with William Weldon, CEO of Johnson + Johnson, on the challenges of leadership in a decentralized company.
Comment?
-
Johnson and Johnson - SWOT Analysis - New Research Report on Companies and Markets
The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Comment?
-
Medtronic targets diabetes device growth
Medtronic Inc is boosting investment in its fast-growing diabetes unit as it aims to convert more diabetics to insulin pumps and continuous glucose monitors, the head of the business said on Monday.
Comment?
-
Abbott stent approval means competition for J&J
The battle over heart stents is heating up again. Abbott Laboratories said today it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V. The approval adds another ...
Comment?
-
Johnson & Johnson CEO: Decentralization Works
Decentralizing management is a good way to spark innovation and train corporate leaders, according to William Weldon , CEO of Johnson & Johnson , maker of Band-Aids and Tylenol.
Comment?
-
I don't think Johnson & Johnson's investors should really care one way or another; the unit's $270 million in sales last year made up less than 1% of Johnson & Johnson's revenue.
Comment?
-
Moessner pointed to Nintendo's winning Wii strategy of creating and encouraging viral videos to support a product that was designed to be inclusive.
Comment?
-
FDA approves Israeli maker's generic version of anti-psychotic Risperdal
Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd.
Comment?
-
Fitch affirms Johnson & Johnson debt ratings, outlook stable
Fitch Ratings on Wednesday affirmed Johnson & Johnson's debt ratings and said ratings outlook was stable for $11.4 billion of debt.
Comment?
-
Open-source venture funding rises
Venture funding for open-source companies rose to $115 million in the second quarter, a 14 percent increase over the same period a year ago, according to The 451 Group .
Comment?
-
Health Winners & Losers: Halozyme
Health stocks traded Tuesday on a variety of business and regulatory news. The Nasdaq and Amex biotechnology indices hopped 1.7% and 1.4%, respectively.
Comment?
-
J&J had planned to spin off the unit, and after opening up the sale to bids decided to enter into exclusive negotiations with One Equity , a private equity firm affiliated with JPMorgan Chase.
Comment?
-
J&J considering sale of wound care unit
Diversified health care products company Johnson & Johnson said Tuesday it is considering an undisclosed buyout offer for its professional wound care business from One Equity Partners.
Comment?
-
J&J receives offer for wound care business
J&J's wound care group is currently a part of its Ethicon medical device division.
Comment?
-
Private Equity Offer for J&J Wound Care Unit
Sign-up for eNews Alerts! Sign up today and stay informed of the latest developments in the New Jersey business community.
Comment?
-
Teva receives FDA approval for generic anti-psychotic drug Risperdal
Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd.
Comment?
-
COURTS Convicted Weiss wants back pay Convicted class-action lawyer Melvyn Weiss asked a court to authorize his old firm, now called Milberg, to pay him for his work there.
Comment?
J and J Snack Foods Forum
Most Popular
